Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Fda pediatric exclusivity grants 2024 complete list?

See the DrugPatentWatch profile for pediatric

Do you want this for U.S. FDA approvals only, and are you looking for items granted in 2024 specifically (i.e., the 6-month pediatric exclusivity awarded in 2024), or a complete historical list including all years with 2024 highlighted?

What I can provide:
- Official source and how to get the list
- How to filter to show only 2024 entries
- Help once you have the data (summaries, formatting, etc.)

Official source and how to pull the list
- The FDA maintains a public page on pediatric exclusivity:
- https://www.fda.gov/drugs/special-features/pediatric-exclusivity
- On that page you’ll find a link to the downloadable list of all drug products with pediatric exclusivity (often provided as an Excel or PDF file). This list includes:
- Drug product name
- Active ingredient
- Applicant/sponsor
- Indication
- FDA approval date
- Date pediatric exclusivity was granted
- Expiration date of the exclusivity

How to get 2024-specific items
- Download the complete pediatric exclusivity list from FDA.
- Filter the list by the “Date pediatric exclusivity was granted” (or equivalent) to isolate entries with a 2024 grant.
- If you want, you can paste the 2024 subset here and I’ll help summarize or format it (e.g., as a bullet list or a table).

If you want me to do the extraction for you, I can guide you step by step or you can share the downloaded file or the 2024 entries and I’ll format and summarize them.



Other Questions About Pediatric :

economic and market drivers chronic shortages essential generic medicines pediatric oncology What research supports cognitive side effects in pediatric lipitor use? Fda pediatric exclusivity 6 months extension standard? Can you specify pediatric omeprazole dosage by weight? Fda pediatric exclusivity 2023 drugs approved? Are there any pediatric specific cosentyx side effects? What are the best ways to manage patent term extension or pediatric exclusivity strategies for innovative medicines?